Electrical Stimulation Therapy and Wound Healing: Where Are We Now?

被引:52
|
作者
Isseroff, R. Rivkah [1 ,2 ,3 ]
Dahle, Sara E. [2 ,4 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA
[2] Northern Calif Hlth Care Syst, Wound Clin, Mather, CA USA
[3] Northern Calif Hlth Care Syst, Dermatol Serv, Mather, CA USA
[4] Northern Calif Hlth Care Syst, Sacramento VA Med Ctr, Podiatry Serv, Mather, CA USA
关键词
D O I
10.1089/wound.2011.0351
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Healing chronic wounds is an ongoing challenge for clinicians and poses a serious public health burden. Electrical stimulation (ES), broadly defined as the application of electrical current via electrodes placed on the skin adjacent to or directly within the wound, has been proposed as a therapeutic modality over a century ago, and recent advances in understanding the biology of electrical phenomena in the skin have rekindled an interest in this modality. The Problem: Despite evidence that has shown ES to be effective for wound healing, it has been slow to gain acceptance in the United States. Also, there has been no consensus in terms of standardization of parameters to devise a systematic protocol for implementation of this technology. Basic/Clinical Science Advances: The epidermis maintains a "skin battery'' that generates an endogenous electric field and current flow when wounded. Experimental models have demonstrated that most of the cell types within the wound can sense an electric field in the range of that endogenously generated in the wound, and respond with a variety of biological and functional responses that can contribute to healing. Multiple animal wound models have demonstrated enhancement of a number of parameters of healing when ES is exogenously supplied. Clinical Care Relevance: Clinical trials have investigated the efficacy of multiple forms of ES for improving healing in a wide variety of human chronic wounds. In 2002 the Centers for Medicare and Medicaid Services approved reimbursement for use of ES in a clinical setting for certain chronic wounds. Conclusion: There remain many voids in our knowledge base: clinical evidence is limited by deficiencies in the design of many of the trials, a multiplicity of ES application modes and waveforms used in trials prevent selection of an optimal modality, and lack of uniformity in reporting ES dosages leave us not much advanced from our clinical knowledge base a decade ago.
引用
收藏
页码:238 / 243
页数:6
相关论文
共 50 条
  • [21] ELECTRICAL-STIMULATION AND WOUND-HEALING
    WEISS, DS
    KIRSNER, R
    EAGLSTEIN, WH
    ARCHIVES OF DERMATOLOGY, 1990, 126 (02) : 222 - 225
  • [22] Monitoring antiplatelet therapy: where are we now?
    Marcucci, Rossella
    Berteotti, Martina
    Gragnano, Felice
    Galli, Mattia
    Cavallari, Ilaria
    Renda, Giulia
    Capranzano, Piera
    Santilli, Francesca
    Capodanno, Davide J.
    Angiolillo, Dominick
    Cirillo, Plinio
    Calabro, Paolo
    Patti, Giuseppe
    De Caterina, Raffaele
    Working Grp Thrombosis
    Italian Soc Cardiology
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 : E24 - E35
  • [23] Where are we now with hormone replacement therapy?
    McPherson, U
    REPRODUCTIVE HEALTH MATTERS, 2004, 12 (24) : 200 - 203
  • [24] GENE THERAPY IN HAEMOPHILIA: WHERE ARE WE NOW?
    Pierce, G. F.
    HAEMOPHILIA, 2021, 27 : 14 - 14
  • [25] Behavior therapy for obesity: where are we now?
    Sarwer, David B.
    Green, Amy von Sydow
    Vetter, Marion L.
    Wadden, Thomas A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (05) : 347 - 352
  • [26] Combination therapy in dyslipidemia: Where are we now?
    Catapano, Alberico L.
    Farnier, Michel
    Foody, JoAnne M.
    Toth, Peter P.
    Tomassini, Joanne E.
    Brudi, Philippe
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2014, 237 (01) : 319 - 335
  • [27] Therapy outcome measures: Where are we now?
    John, Alexandra
    INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2011, 13 (01) : 36 - 42
  • [28] Neoadjuvant Therapy in Melanoma: Where Are We Now?
    Saad, Mariam
    Tarhini, Ahmad A.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (04) : 325 - 339
  • [29] Occupational therapy awareness: Where are we now?
    Kingsland, Nancy
    Wilson, Angela
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2008, 15 (01): : 6 - 6
  • [30] Neoadjuvant Therapy in Melanoma: Where Are We Now?
    Mariam Saad
    Ahmad A. Tarhini
    Current Oncology Reports, 2023, 25 : 325 - 339